New study tracks blood thinner safety in infants and toddlers
NCT ID NCT05900388
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study looks at how blood thinners like rivaroxaban are used in children under 2 years old who have blood clots. Researchers will collect information from medical records and insurance claims to see how well these medicines work and if they cause serious bleeding. No extra tests or treatments are needed—just observation of usual care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOEMBOLISM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
Multiple Locations, Denmark
-
Many locations
Multiple Locations, France
-
Many locations
Multiple Locations, Spain
-
Many locations
Multiple Locations, Sweden
Conditions
Explore the condition pages connected to this study.